Clinical Trials Browser

Phase 3 × Leiomyosarcoma × ADI PEG20 × Clear all

NCT05712694 2025-07-17

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Phase 3 Recruiting

Leiomyosarcoma, Sarcoma